Article Data

  • Views 466
  • Dowloads 108

Case Reports

Open Access

Association of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and high-grade undifferentiated endometrial sarcoma: a case report

  • L.Di Benedetto1,*,
  • A. Guarino1
  • M. Mallozzi1
  • D. Caserta1

1Department of Medical and Surgical Sciences and Translational Medicine, Sant’Andrea Hospital, Faculty of Medicine and Psychology, University of Rome “Sapienza”, Rome (Italy)

DOI: 10.12892/ejgo3973.2017 Vol.38,Issue 4,August 2017 pp.638-641

Published: 10 August 2017

*Corresponding Author(s): L.Di Benedetto E-mail: luisadibenedetto@outlook.it

Abstract

Endometriosis is a chronic disease that affects women of reproductive age. Malignant transformation in endometriosis is considered to be an unusual event, only occurring in 0.7–0.1% of cases. However the association between endometriosis and endometrial cancer is not well defined. Also in literature, rare cases of uterine sarcoma, about 3% of all uterine malignancies, associated with endometriosis have been reported. The authors report a case of a 47-years-old Italian woman with histologic diagnosis of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and undifferentiated endometrial sarcoma. Therefore there have been few studies addressing the relationship between endometrial stromal sarcomas (ESS), and endometriosis. Novel scientific findings are necessary to investigate a possible common pathway and an effective treatment, although complete tumor resection can reduce the recurrence rate.

Keywords

Endometriosis; Endometrial stromal sarcomas; Endometrial cancer.

Cite and Share

L.Di Benedetto,A. Guarino,M. Mallozzi,D. Caserta. Association of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and high-grade undifferentiated endometrial sarcoma: a case report. European Journal of Gynaecological Oncology. 2017. 38(4);638-641.

References

[1] Yu H.C., Lin C.Y., Chang W.C., Shen B.J., Chang W.P., Chuang C.M., Task Force on Carcinogenesis of Endometrial Cancer: “Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study”. Int. J. Gynecol. Cancer, 2015, 25, 447.

[2] Burghaus S., Häberle L., Schrauder M.G., Heusinger K., Thiel F.C., Hein A.: “- results of a hospital-based case-control study”. BMC Cancer, 2015, 15, 751.

[3] Tropé C.G., Abeler V.M., Kristensen G.B.: “Diagnosis and treatment of sarcoma of the uterus. A review”. Acta Oncol., 2012, 51, 694.

[4] Philip C.A., Pautier P., Duffaud F., Ray-Coquard I.: “High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches”. Curr. Oncol. Rep., 2014, 16, 405

[5] Xu Y., Zhu H., Zhao D., Tan J.: “Endometrial stem cells: clinical application and pathological roles”. Int. J. Clin. Exp. Med., 2015, 8. 22039.

[6] Brustmann H., Geiss I.M., Hinterholzer S.: “Undifferentiated Endometrial Sarcoma of the Ovary: A Case Report with Review of Recent Literature and Discussion of Lacking Specificity of CD10 Immunoreactivity”. Patholog Res. Int., 2010, 2010, 608519.

[7] Lan C., Huang X., Lin S., Cai M., Liu J.: “Endometrial stromal sarcoma arising from endometriosis: a clinicopathological study and literature review”. Gynecol. Obstet. Invest., 2012, 74, 288.

[8] Stomati M., Corso S. ,Trezza F., Sorrentino F. ,Nappi L., Pellegrino A., Potì M.: “Endometriosis and cancer”. Multidisciplinary Journal of Woman’s Health, 2014, 3, 11.

[9] Bulun S.E., Monsavais D., Pavone M.E., Dyson M., Xue Q., Attar E., et al.: “Role of estrogen receptor-beta in endometriosis”. Semin. Reprod. Med., 2012, 30, 39.

[10] Skrzypczak M., Bieche I., Szymczak S., Tozlu S., Lewandowski S., Girault I., et al.: “Evaluation of mRNAexpression of estrogen receptor beta and its isoforms in human normal and neoplastic endometrium”. Int. J. Cancer, 2004, 110, 783.

[11] Collins F., MacPherson S., Brown P., Bombail V., Williams A.R., Anderson R.A., et al.: “Expression of oestrogen receptors, ERalpha, ERbeta, and ERbetavariants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha”. BMC Cancer, 2009, 9, 330.

[12] Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A., Buller R.E.: “Simultaneously detected endometrial and ovarian carcinomas—a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study”. Gynecol. Oncol., 2001, 83, 355.

[13] Fowler J.M., Ramirez N., Cohn D.E., Kelbick N., Pavelka J., BenShachar I., Morrison C.: “Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis”. Am. J. Obstet. Gynecol., 2005, 192, 1262.

[14] Kim J.Y., Hong S.Y., Sung H.J., Oh H.K., Koh S.B.: “A case of multiple metastatic low-grade endometrial stromal sarcoma arising from an ovarian endometriotic lesion”. J. Gynecol. Oncol., 2009, 20, 122.

[15] Puliyath G., Nair M.K.: “Endometrial stromal sarcoma: a review of the literature”. Indian J. Med. Paediatr. Oncol., 2012, 33, 1.

[16] Ali R.H., Rouzbahman M.: “Endometrial stromal tumours revisited: an update based on the 2014 WHO classification”. J. Clin. Pathol., 2015, 68, 325.

[17] Wang Q., Zhao X., Han P.: “Endometrial stromal sarcoma arising in colorectal endometriosis: a case report and review of the literature”. Case Rep. Obstet. Gynecol., 2015, 2015, 534273.

[18] Fadare O., McCalip B., Mariappan M.R., Hileeto D., Parkash V.: “An endometrial stromal tumor with osteoclast-like giant cells”. Ann Diagn Pathol., 2005 9, 160.

[19] El-Khalfaoui K., du Bois A., Heitz F., Kurzeder C., Sehouli J., Harter P.: “Current and future options in the management and treatment of uterine sarcoma”. Ther. Adv. Med. Oncol., 2014, 6, 21.

[20] Back J.A., Choi M.G., Ju U.C., Kang W.D., Kim S.M.: “A case of advanced-stage endometrial stromal sarcoma of the ovary arising from endometriosis”. Obstet. Gynecol. Sci., 2016, 59, 323.

[21] Tanner E.J., Garg K., Leitao M.M. Jr., Soslow R.A., Hensley M.L.: “High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes”. Gynecol. Oncol., 2012, 127, 27.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top